CXCL9 and nasopharyngeal carcinoma: The potential anti-tumor capacity of NPC-derived macrophage is exhibited by its high expression of CXC chemokine ligands CXCL9 and CXCL10 which recruit CXCR3+ NK cells and CD8+ T-cells into the TME (20).